Panacea Biotec Ltd. benchmarking: Performance to industry peers

Financial

	Panacea Biotec	Unichem Lab	Indoco Remedies
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	6.0 .	41.0 .	54.0 .
R&D as a % of Total Sales	9.86 %	5.35 %	5.7 %
Financials
5 yr Average ROE	37.52 %	1.64 %	10.38 %
5yr average Equity Multiplier	0.36	1.32	1.9
5yr Average Asset Turnover Ratio	0.41	0.47	0.88
5yr Avg Net Profit Margin	26.1 %	-1.68 %	5.41 %
Price to Book	2.39	0.87	1.79
P/E	0.0	7.16	0.0
5yr Avg Cash Conversion Cycle	-170.26 Days	88.84 Days	35.3 Days
Inventory Days	120.03 Days	151.32 Days	70.6 Days
Days Receivable	42.2 Days	122.86 Days	83.16 Days
Days Payable	325.14 Days	205.05 Days	111.01 Days
5yr Average Interest Coverage Ratio	2.7	2.41	7.53
5yr Avg ROCE	-2.79 %	1.04 %	13.6 %
5yr Avg Operating Profit Margin	-3.85 %	5.43 %	14.97 %
5 yr average Debt to Equity	-0.69	0.11	0.49
5yr CAGR Net Profit	-43.68 %	32.0 %	n/a
5yr Average Return on Assets	9.32 %	-0.65 %	5.31 %
Shareholdings
Promoter Holding	72.48 %	70.22 %	58.9 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-1.11 %	19.29 %	0.21 %
Change in Mutual Fund Holding (3 Yrs)	0.0	2.39 %	0.27 %

Business

	Panacea Biotec	Unichem Lab	Indoco Remedies
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Anti - Diabetes 43.91 Gastro Intestinal 13.47 Pain Management 12.87 Anti-Neoplastics 8.18 Vitamins / Minerals / Nutrients 6.09 Respiratory Systems 5.39 Vaccines 5.39 Blood Related 2.99 Hormones 0.6 Cardiac 0 Urological 0 Dermatology 0 Gynaecology 0 Pain / Analgesics 0 Ophthal / Otologicals 0 Vitamins / Minerals / Nutrients 0 Anti-Infectives 0 Stomatologicals 0 Others 1.11	-	Therapeutic Area Wise Break-Up - Domestic Cardiac Science 3.12 Urology 8.44 Vitamins / Minerals / Nutrients 9.07 Vaccines 0 Anti - Diabetes 0 Respiratory Systems 0 Pain Management 3.41 Pain Management 0 Gynecology 1.17 Ophthalmology 5.88 Gastro Intestinal 18.13 Hormones 0 Stomatologicals 13.47 Anti-Neoplastics 0 Blood Related 0 Dermatology 5.05 Anti-Infective 15.18 Others 17.08
Product Wise Break-Up	Product Wise Break-Up Vaccines 60.08 Formulations 39.92 Research and Development 0 Bulk Drugs and chemicals 0 CRO, Analytical Services 0 API 0 Formulation 0	Product Wise Break-Up CRO, Analytical Services 0 Formulations 92.3 Vaccines 0 API 0 Formulation 0 Research and Development 0 Bulk Chemicals 7.7	Product Wise Break-Up CRO, Analytical Services 1.0 Formulations 0 Vaccines 0 Active Pharmaceutical Ingredient (API) 9.0 Formulations 90.0 Research and Development 0 Bulk Drugs and chemicals 0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 86.09 India 13.91 USA 0	Location Wise Break-Up Rest of the World 0 USA 64.2 India 1.97 Others 33.83	Location Wise Break-Up Rest of the World 31.98 USA 0 India 68.02
Operating Profit Break-Up	Operating Profit Break-Up Others 100	-	-
Capex	Capex Vaccines 69.46 Formulations 30.54 Real estate 0	-	-
Brand Wise Break-Up	Brand Wise Break-Up PanGraf 21.0 Glizid Family 19.0 Sitcom Family 10.0 Mycept & Mycept 5.0 Livoluk Family 4.0 Panimun Bioral 4.0 PacliAll 1.0 Thank OD Family 0 Nimulid Family 0 Others 36.0	-	-
Asset Break-Up	Asset Break-Up Vaccines 68.98 Formulations 31.02 Real Estate 0	-	-

Panacea Biotec Ltd.

Panacea Biotec Ltd.

Financial

Business

SIGN UP FOR FREE